EC Number | Application | Comment | Organism |
---|---|---|---|
5.3.99.2 | medicine | the results demonstrate that the neuroprotective effects of hematopoietic prostaglandin D synthase in the model are mediated by suppression of activation and infiltration of inflammatory cells | Mus musculus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
5.3.99.2 | 4-benzhydryloxy-1-[3-(1H-tetrazol-5-yl)-propyl]piperidine | HQL-79 | Mus musculus |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
5.3.99.2 | 26000 | - |
determined by SDS-PAGE and Western Blot analysis | Mus musculus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
5.3.99.2 | Prostaglandin H2 | Mus musculus | - |
Prostaglandin D2 | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
5.3.99.2 | Mus musculus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
5.3.99.2 | brain | ischemic region, contralateral cortex | Mus musculus | - |
5.3.99.2 | microglia | - |
Mus musculus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
5.3.99.2 | Prostaglandin H2 | - |
Mus musculus | Prostaglandin D2 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
5.3.99.2 | Hematopoietic prostaglandin D synthase | - |
Mus musculus |
5.3.99.2 | HPGDS | - |
Mus musculus |